Idarucizumab, an investigational drug, rapidly and completely neutralizes the anticoagulant activity of dabigatran in most patients who have serious bleeding or require an urgent procedure, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback